UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-02 | Future report Set alerts | |
| Q2 2022 | 2022-08-04 | 0.00 | 0.00 |
| Q1 2022 | 2022-05-05 | -0.43 | -0.43 |
| Q4 2021 | 2022-03-01 | -0.40 | -0.40 |
| Q3 2021 | 2021-11-04 | -0.43 | -0.43 |
| Q2 2021 | 2021-08-03 | -0.39 | -0.39 |
| Q1 2021 | 2021-05-06 | -0.26 | -0.26 |
| Q4 2020 | 2021-03-04 | -0.35 | -0.35 |
| Q3 2020 | 2020-11-05 | -0.24 | -0.24 |
| Q2 2020 | 2020-08-06 | -0.25 | -0.25 |
| 2016-03-14 | Downgrade | Northland Securities | Outperform to Underperform | |
| 2016-02-09 | Downgrade | Northland Securities | Outperform to Sell | |
| 2015-08-05 | Downgrade | Canaccord Genuity | Buy to Hold | $2.50 to $1.00 |
| 2015-05-14 | Initiated Coverage | Northland Securities | Outperform | $3.00 |
| 2015-05-01 | Lower Price Target | Canaccord Genuity | Buy | $3.00 to $2.50 |
| 2015-02-27 | Reiterated Rating | Canaccord Genuity | Buy | $3.00 |
| 2014-05-01 | Reiterated Rating | Jefferies Group | Buy | |
| 2014-03-18 | Initiated Coverage | Canaccord Genuity | Buy | $3.00 |
| 2014-03-18 | Lower Price Target | Jefferies Group | $3.00 to $2.70 | |
| 2013-11-08 | Boost Price Target | Jefferies Group | Buy | $2.50 to $3.00 |
| 2010-12-28 | Reiterated | Stifel Nicolaus | Buy | $3.25 to $3.10 |
| 2010-09-02 | Initiated | Stifel Nicolaus | Buy | $3.25 |
| 2010-08-06 | Downgrade | RBC Capital Mkts | Outperform to Sector Perform | $8 to $4.50 |
| 2010-08-06 | Downgrade | Maxim Group | Buy to Hold | |
| 2010-06-21 | Initiated | Boenning & Scattergood | Outperform | $7 |
| 2010-04-27 | Initiated | Jefferies | Buy | $8 |
| 2010-04-14 | Reiterated | Deutsche Bank | Hold | $4.50 to $6 |
| 2010-04-07 | Initiated | Maxim Group | Buy | $8 |
| 2010-03-10 | Upgrade | RBC Capital Mkts | Sector Perform to Outperform | |
| 2009-10-21 | Initiated | Roth Capital | Buy | $7 |
| 2009-08-04 | Reiterated | RBC Capital Mkts | Sector Perform | $2 to $4 |
| 2009-03-03 | Reiterated | Canaccord Adams | Buy | $7.50 to $4 |
| 2009-02-26 | Initiated | RBC Capital Mkts | Sector Perform | |
| 2008-12-10 | Reiterated | Noble Financial | Buy | $8.50 to $6 |
| 2008-09-18 | Initiated | Rodman & Renshaw | Mkt Perform | |
| 2008-08-05 | Reiterated | Canaccord Adams | Buy | $6.75 to $7.50 |
| 2007-10-01 | Reiterated | Canaccord Adams | Buy | $5.25 to $6 |
| 2007-02-23 | Reiterated | Deutsche Securities | Hold | $4 to $5 |
| 2016-03-14 | Downgrade | Northland Securities | Outperform to Underperform | |
| 2016-02-09 | Downgrade | Northland Securities | Outperform to Sell | |
| 2015-08-05 | Downgrade | Canaccord Genuity | Buy to Hold | $2.50 to $1.00 |
| 2015-05-14 | Initiated Coverage | Northland Securities | Outperform | $3.00 |
| 2015-05-01 | Lower Price Target | Canaccord Genuity | Buy | $3.00 to $2.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ATEC 106 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 4.94M |
| Vanguard Group, Inc | 3.50M |
| First Light Asset Management, LLC | 2.97M |
| DEERFIELD MANAGEMENT CO | 2.53M |
| ARMISTICE CAPITAL, LLC | 2.44M |
| CHUBB CORP | 2.30M |
| HENDERSON GROUP PLC | 1.94M |
| NEXT CENTURY GROWTH INVESTORS LLC | 1.92M |
| STATE STREET CORP | 1.75M |
| JPMORGAN CHASE & CO | 1.59M |
| KING LUTHER CAPITAL MANAGEMENT CORP | 1.39M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.34M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.32M |
| PENN CAPITAL MANAGEMENT CO INC | 1.24M |
| ROYAL BANK OF CANADA | 1.22M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Foster John | 21.45% (21010565) | ATEC / |
| HEALTHPOINTCAPITAL PARTNERS II L P | 21.45% (21010565) | ATEC / |
| HGP II, LLC | 21.45% (21010565) | ATEC / |
| HGP LLC | 11.00% (10777173) | ATEC / |
| HealthpointCapital Partners LP | 11.00% (10777173) | ATEC / |
| Miles Patrick Executive Chairman | 2.38% (2327434) | ATEC / NUVA / |
| Kuyper Dirk President and CEO | 0.57% (559128) | ATEC / CNMD / |
| WOODS WARD W JR | 0.51% (500000) | ATEC / |
| Rich Terry Chief Executive Officer | 0.47% (457958) | ATEC / TRNX / |
| Blackford Quentin S. | 0.45% (442478) | ATEC / DXCM / NUVA / |
| Hunsaker Craig E See Remarks | 0.44% (427388) | ATEC / NUVA / |
| Asai Mitsuo President, Alphatec Pacific | 0.28% (276566) | ATEC / |
| Berkowitz Mortimer III | 0.21% (200933) | ATEC / |
| Rydin Jeffrey P | 0.20% (200434) | ATEC / |
| Plunkett Michael Joseph Chief Operating Officer | 0.20% (200127) | ATEC / FMD / |
| Allen Jonathan See Remarks | 0.20% (200000) | ATEC / |
| Ryan Patrick Chief Operating Officer | 0.17% (166466) | ATEC / PODD / |
| O'Neill Michael CFO and Vice President | 0.14% (138653) | ATEC / |
| Snider Brian See Remarks | 0.13% (128000) | ATEC / |
| GLYNN JAMES R | 0.13% (127175) | ATEC / |
| MARSHALL SIRI S | 0.11% (112175) | AMP / ATEC / EFX / |
| DESAI ROHIT M | 0.11% (112175) | ATEC / |
| Lubischer Stephen VP, Sales | 0.09% (86527) | ATEC / |
| CROSS LESLIE H | 0.09% (84382) | ATEC / |
| CORBETT JAMES President and CEO | 0.08% (77082) | ATEC / |
| Howell Kelli Mari EVP, Clinical Strategies | 0.05% (50000) | ATEC / |
| FAULSTICK LUKE T | 0.05% (46260) | ATEC / OFIX / |
| Black Jeffrey G. Executive VP & CFO | 0.03% (34000) | ATEC / |
| DAVIS TOM C | 0.03% (33334) | AFFM / ATEC / DF / |
| Oneil Stephen | 0.03% (33006) | ATEC / |
| Molson R Ian | 0.03% (31834) | ATEC / |
| Stott Kermit P. VP, Operations | 0.03% (25366) | ATEC / |
| Williams Donald Allen | 0.02% (21941) | ATEC / CLTX / MRNA / |
| Mowry David H | 0.02% (18939) | ATEC / TRNX / |
| Nelson Dennis VP, Finance and Controller | 0.02% (16497) | ATEC / |
| TIMM JENS PETER VP, Research and Development | 0.01% (13278) | ATEC / |
| Garner Ebun General Counsel and SVP | 0.01% (8545) | ATEC / |
UM